Ajan Reginald

Company: Roquefort Therapeutics plc

Job title: Chief Executive Officer


Showcasing the Future Potential for mRNA-Based Vaccines & Therapeutics to Effectively Treat Cancer 4:00 pm

Session Details TBCRead more

day: Day 2 PM

Fireside Discussion: Tissue-Specific Targeting of mRNA to Increase Therapeutic Efficacy 1:15 pm

Analysing cellular and tissue characteristics for successful uptake of mRNA- based therapeutics without inflammation Improving formulations to enhance mRNA specificity and eliminate mis-targeting to alternative cellular populations How can understanding biodistribution overcome challenges of target specificity?Read more


A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.